277 (Januvia 100 mg)
Generic Name: sitagliptin
Pill imprint 277 has been identified as Januvia 100 mg.
Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 277 (Januvia 100 mg)
- Generic Name:
- 100 mg
- 10.00 mm
- Prescription only
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Merck & Company Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
ferric oxide red
sodium stearyl fumarate
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|54569-5925||A S Medication Solutions LLC (repackager)|
|54868-5840||Physicians Total Care Inc (repackager)|
|35356-0103||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
Januvia is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...